RXO (NYSE:RXO) Price Target Raised to $18.00

RXO (NYSE:RXOFree Report) had its price target hoisted by Susquehanna from $14.00 to $18.00 in a report released on Friday morning, Marketbeat Ratings reports. Susquehanna currently has a negative rating on the stock.

RXO has been the subject of a number of other research reports. Citigroup raised their price target on shares of RXO from $15.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 9th. Bank of America lowered their price target on shares of RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a report on Wednesday, March 25th. Wells Fargo & Company raised their price target on shares of RXO from $15.00 to $22.00 and gave the company an “equal weight” rating in a report on Friday. Morgan Stanley reissued an “equal weight” rating and issued a $22.00 price target (up from $19.00) on shares of RXO in a report on Thursday. Finally, Zacks Research raised shares of RXO from a “strong sell” rating to a “hold” rating in a report on Monday, April 6th. Two investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $19.54.

Read Our Latest Research Report on RXO

RXO Stock Performance

NYSE RXO opened at $21.80 on Friday. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of -35.74, a PEG ratio of 32.97 and a beta of 1.96. The company has a 50 day moving average of $15.96 and a 200-day moving average of $15.01. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28. RXO has a 1-year low of $10.43 and a 1-year high of $23.37.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.09) earnings per share for the quarter, hitting the consensus estimate of ($0.09). The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.34 billion. RXO had a negative net margin of 1.83% and a negative return on equity of 1.16%. The company’s revenue was down .6% on a year-over-year basis. During the same quarter last year, the business posted ($0.03) earnings per share. On average, equities analysts forecast that RXO will post 0.02 earnings per share for the current fiscal year.

Hedge Funds Weigh In On RXO

Hedge funds and other institutional investors have recently bought and sold shares of the business. Principal Financial Group Inc. boosted its stake in RXO by 11.8% in the third quarter. Principal Financial Group Inc. now owns 791,799 shares of the company’s stock valued at $12,178,000 after acquiring an additional 83,305 shares during the last quarter. Finepoint Capital LP bought a new position in RXO in the third quarter valued at approximately $111,764,000. Cornerstone Wealth Group LLC bought a new position in RXO in the third quarter valued at approximately $4,026,000. Public Sector Pension Investment Board boosted its stake in RXO by 31.6% in the third quarter. Public Sector Pension Investment Board now owns 639,606 shares of the company’s stock valued at $9,837,000 after acquiring an additional 153,468 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in RXO by 1.4% in the third quarter. Vanguard Group Inc. now owns 17,216,681 shares of the company’s stock valued at $264,793,000 after acquiring an additional 233,434 shares during the last quarter. 92.73% of the stock is owned by institutional investors.

Key RXO News

Here are the key news stories impacting RXO this week:

  • Positive Sentiment: RXO reported Q1 adjusted results that matched EPS expectations and beat revenue estimates, helping ease concerns about demand trends and Amazon-related weakness. RXO Announces First-Quarter Results and Second-Quarter Outlook
  • Positive Sentiment: The company’s Q2 outlook also topped Street expectations, with management projecting $27 million to $37 million in adjusted EBITDA and saying contract rates are trending toward high-single-digit gains. RXO expects $27M-$37M Q2 adjusted EBITDA…
  • Positive Sentiment: Management said brokerage momentum is improving, full truckload volume strengthened through the quarter, and higher spot mix should support margins going forward. RXO raises contract rate outlook as Q2 profit seen higher
  • Neutral Sentiment: Analysts raised price targets after the report, with TD Cowen lifting its target to $21 and Susquehanna increasing its target to $18, but both firms kept cautious ratings. Analyst updates on RXO
  • Negative Sentiment: RXO still posted a quarterly loss, and revenue was slightly down year over year, so investors remain focused on whether improved pricing and volume can translate into sustained profitability. RXO Reports Q1 Loss…

RXO Company Profile

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Further Reading

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.